+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunotherapy"

Allergy Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Allergy Treatment Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 198 Pages
  • Global
From
Systemic Lupus Erythematosus Market - Global Forecast 2025-2032 - Product Thumbnail Image

Systemic Lupus Erythematosus Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 180 Pages
  • Global
From
From
Pediatric Oncology Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pediatric Oncology Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
From
From
Molecular Oncology Market - Global Forecast 2025-2030 - Product Thumbnail Image

Molecular Oncology Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
Aß Monoclonal Antibody Drug Market - Global Forecast 2025-2030 - Product Thumbnail Image

Aß Monoclonal Antibody Drug Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Allergen Specific IgE Tests Market - Global Forecast 2025-2030 - Product Thumbnail Image

Allergen Specific IgE Tests Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Immunology Market - Global Forecast 2025-2030 - Product Thumbnail Image

Immunology Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
From
From
LAG-3 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

LAG-3 Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
TIGIT Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

TIGIT Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CD47 Antigen Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

CD47 Antigen Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 And PD-L1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
4-1BB Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

4-1BB Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Rhinitis - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Loading Indicator

Immunotherapy is a type of treatment used to treat immune disorders, such as allergies, asthma, and autoimmune diseases. It works by stimulating the body's own immune system to fight off disease-causing agents. Immunotherapy drugs are designed to target specific parts of the immune system, such as T-cells, B-cells, and cytokines. These drugs can be used to treat a variety of conditions, including cancer, HIV/AIDS, and rheumatoid arthritis. Immunotherapy drugs are typically administered through injections, infusions, or oral medications. They can also be used in combination with other treatments, such as chemotherapy or radiation therapy. The goal of immunotherapy is to reduce the severity of symptoms and improve the patient's quality of life. The immunotherapy market is a rapidly growing sector of the pharmaceutical industry. Companies in this market are focused on developing new treatments and therapies to treat immune disorders. Some of the major players in this market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more